ERBB2 and neoplasm: Additionally,the binding specificity of the immunoSCIFI probe for HER2 was evaluatedin a cellular assay that showed significantly higher binding to SKBR3(high HER2 expression) relative to MDA-MB-468 (low HER2) breast cancercells based on measurements of total flux in the near-infrared regionwith external excitation blocked.